Diagnostic Performance of Serum Interferon Gamma, Matrix Metalloproteinases, and Periostin Measurements for Pulmonary Tuberculosis in Japanese Patients with Pneumonia
Overview
Authors
Affiliations
Serum markers that differentiate between tuberculous and non-tuberculous pneumonia would be clinically useful. However, few serum markers have been investigated for their association with either disease. In this study, serum levels of interferon gamma (IFN-γ), matrix metalloproteinases 1 and 9 (MMP-1 and MMP-9, respectively), and periostin were compared between 40 pulmonary tuberculosis (PTB) and 28 non-tuberculous pneumonia (non-PTB) patients. Diagnostic performance was assessed by analysis of receiver-operating characteristic (ROC) curves and classification trees. Serum IFN-γ and MMP-1 levels were significantly higher and serum MMP-9 levels significantly lower in PTB than in non-PTB patients (p < 0.001, p = 0.002, p < 0.001, respectively). No significant difference was observed in serum periostin levels between groups. ROC curve analysis could not determine the appropriate cut-off value with high sensitivity and specificity; therefore, a classification tree method was applied. This method identified patients with limited infiltration into three groups with statistical significance (p = 0.01), and those with MMP-1 levels < 0.01 ng/mL and periostin levels ≥ 118.8 ng/mL included only non-PTB patients (95% confidence interval 0.0-41.0). Patients with extensive infiltration were also divided into three groups with statistical significance (p < 0.001), and those with MMP-9 levels < 3.009 ng/mL included only PTB patients (95% confidence interval 76.8-100.0). In conclusion, the novel classification tree developed using MMP-1, MMP-9, and periostin data distinguished PTB from non-PTB patients. Further studies are needed to validate our cut-off values and the overall clinical usefulness of these markers.
Schrijver B, Gopfert J, La Distia Nora R, Putera I, Nagtzaam N, Smits Te Nijenhuis M Heliyon. 2024; 10(18):e37103.
PMID: 39309852 PMC: 11416298. DOI: 10.1016/j.heliyon.2024.e37103.
Yao F, Zhang R, Lin Q, Xu H, Li W, Ou M Emerg Microbes Infect. 2024; 13(1):2370399.
PMID: 38888093 PMC: 11225635. DOI: 10.1080/22221751.2024.2370399.
The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
Li M, Ma G, Li X, Zhou Q Med Sci Monit. 2022; 28:e936898.
PMID: 35891604 PMC: 9341396. DOI: 10.12659/MSM.936898.
Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae.
Shanmugasundaram K, Talwar A, Madan K, Bade G Tuberc Respir Dis (Seoul). 2022; 85(2):175-184.
PMID: 35232004 PMC: 8987661. DOI: 10.4046/trd.2021.0127.
Ono J, Takai M, Kamei A, Azuma Y, Izuhara K Biomolecules. 2021; 11(8).
PMID: 34439751 PMC: 8391913. DOI: 10.3390/biom11081084.